Know Labs Announces Executive Leadership Changes and Confirms 2023 Outlook morningstar.com/news/business-…

Know Labs Provides Update on Strategic Partners Engaged in Data Science, Product Engineering and Regulatory Affairs to Accelerate Progress Toward FDA Application businesswire.com/news/home/2023…

Know Labs Forms New Scientific Advisory Board, Appoints Respected Researchers in Medical Innovation knowlabs.co/post/know-labs…

Know Labs Demonstrates Accuracy of Non-Invasive, Bio-RFID Technology with Proof-of-Principle Study knowlabs.co/post/know-labs…

Know Labs Study Validates Technical Feasibility of Novel Sensor for Non-Invasive Glucose Monitoring knowlabs.co/post/know-labs…

A writeup in Benzinga today covers our partnership with Edge Impulse and showcases our work as a prime example for how responsible ML applications can significantly improve healthcare diagnostics. benzinga.com/general/biotec…

Our CEO and Chairman, Ron Erickson wrote an article for Forbes on how emerging technologies will increase access, lead to better, more cost-effective treatment options and help to democratize healthcare. forbes.com/sites/forbeste…

We are thrilled to announce our first peer-reviewed publication in the scientific journal, Sensors MDPI, of our proof-of-principle study conducted in collaboration with the Mayo Clinic! Read the full manuscript here: mdpi.com/1424-8220/23/1…

We’re excited to share that our CFO and SVP of IP, Pete Conley, will be speaking on the “Make Your CFO an IP Believer” panel at the 2023 #IPBCGlobal to discuss the importance of strategic #IP development in maximizing shareholder value. Read more here: knowlabs.co/post/know-labs…

Today we released the results of a new study that demonstrates improved accuracy for our Bio-RFID technology in predicting blood glucose, using the Dexcom G6® as a reference device. Learn more about the study here: knowlabs.co/research-and-v… #medicaldevices #glucosemonitoring

Announcing our Generation 1 Prototype – a big step forward as we work toward developing the first FDA-cleared, non-invasive glucose monitoring device. Learn more here: knowlabs.co/post/know-labs…

The completion of the Gen 1 Prototype marks a significant achievement for our team and our partners, Igor Institute, Bould Design, Reza Kassayan, and Edge Impulse. Watch our development progress over the years: youtu.be/vWwMOQV3gz0

Know Labs recently unveiled the prototype for its non-invasive, portable glucose monitoring device. The device incorporates the company’s proprietary body-radio frequency identification (Bio-RFID) technology — meaning its sensors deploy radio waves... ow.ly/QKfF104K8YF

Our CEO and Chairman, Ron Erickson wrote an article for Forbes on how better, earlier detection and diagnosis of prediabetes could prevent the growing incidence of type 2 diabetes, especially among people 20 years old or younger. forbes.com/sites/forbeste…

Today we released the results of a new study demonstrating that continued algorithm refinement and more high-quality data improved the accuracy of our Bio-RFID technology. Learn more about the study here: knowlabs.co/research-and-v…

Our Chief Medical Officer, Dr. James (Andy) Anderson recently spoke with Sarah Glinski and Forbes Health about diet and lifestyle changes effective for treating insulin resistance. Read the article to learn more: forbes.com/health/conditi…

Our CEO and Chairman, Ron Erickson was featured in Authority Magazine’s "The Future is Now: Exciting Emerging Technology". The article covers Ron’s storied career and how Know Labs’ novel technology could be the future standard of patient care. Read here: medium.com/authority-maga…

We're returning to this year’s Bernstein CGM Disruptors Conference, where our CFO and SVP of IP, Pete Conley, will present significant updates on our progress over the past year and our path to FDA clearance. Read the full announcement here: knowlabs.co/post/know-labs…

Today, we announce the KnowU™, our non-invasive wearable CGM that incorporates the sensor we plan to submit to the FDA for clearance. We’re now closer to bringing the device to the global marketplace and providing equitable care in #diabetes management youtube.com/watch?v=9ohXLe…

Today we announced the interim results from our latest clinical research study. We will present the results of the study at the 17th International Advanced Technologies & Treatments for Diabetes in Florence, Italy on March 6-9, 2024. knowlabs.co/post/know-labs…